CL vs PG
Colgate Palmolive Co. and Procter & Gamble Co., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CL | PG |
|---|---|---|
| Revenue | $20.4B | $87.0B |
| Net income | $2.1B | $16.0B |
| Gross margin | 60.1% | 50.2% |
| Net margin | 11.1% | 18.5% |
| Return on equity | 1603.0% | — |
| Diluted EPS | $2.63 | $6.62 |
| Dividend / share | $2.08 | $4.26 |
| Payout ratio | — | 63.8% |
| Free cash flow | $3.6B | $15.1B |
| Equity | $54.0M | — |
| Net debt / equity | 124.04× | — |
| Current ratio | 0.83× | 0.68× |
| Revenue CAGR 5y | 4.4% | 2.7% |
| Profit CAGR 5y | −4.6% | 2.3% |
PG bills 4.3× the revenue of CL, and keeps more of each dollar of revenue as profit (18.5% against 11.1%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CL | PG |
|---|---|---|
| FY2025 | $20.4B | $87.0B |
| FY2024 | $20.1B | $84.3B |
| FY2023 | $19.5B | $84.0B |
| FY2022 | $18.0B | $82.0B |
| FY2021 | $17.4B | $80.2B |
| FY2020 | $16.5B | $76.1B |
| FY2019 | $15.7B | $71.0B |
| FY2018 | $15.5B | $67.7B |
| FY2017 | $15.5B | $66.8B |
| FY2016 | $15.2B | $65.1B |
Net income by year
Bottom line
| Fiscal year | CL | PG |
|---|---|---|
| FY2025 | $2.1B | $16.0B |
| FY2024 | $2.9B | $16.0B |
| FY2023 | $2.3B | $14.9B |
| FY2022 | $1.8B | $14.7B |
| FY2021 | $2.2B | $14.7B |
| FY2020 | $2.7B | $14.3B |
| FY2019 | $2.4B | $13.0B |
| FY2018 | $2.4B | $3.9B |
| FY2017 | $2.0B | $9.8B |
| FY2016 | $2.4B | $15.3B |